| PCSA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PCSA shares outstanding history going back to 7/31/2020:
Also see: PCSA Market Cap History PCSA YTD Return |
PCSA Shares Outstanding History — Processa Pharmaceuticals Share Count Over Time
As of 8/7/2026 Processa Pharmaceuticals has 2.79 million PCSA shares outstanding. Investors often track the PCSA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PCSA share count trends over time, with 27 historical shares outstanding datapoints presented, dating back to 7/31/2020.
| PCSA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCSA Historical Shares Outstanding: +150.68% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PCSA Stock Price Chart |
| About Processa Pharmaceuticals Inc |
| Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on utilizing its regulatory science approach, including the principles associated with food and drug administration (FDA's) Project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (NGC) oncology drug products. The three NGC treatments in its pipeline are NGC-Capecitabine (NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem) and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri). NGC-Cap is a combination of PCS6422 and capecitabine, capecitabine being the oral prodrug of the cancer drug 5-fluorouracil. We show 27 historical shares outstanding datapoints in our coverage of PCSA's shares outstanding history. Understanding the changing numbers of PCSA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PCSA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PCSA by allowing them to research PCSA shares outstanding history as well as any other stock in our coverage universe. |
| PCSA Current Stock Quote |
Quotes delayed 20 minutes  Free PCSA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| PCSA Share Performance |
| Shares Outstanding Peers |
| Processa Pharmaceuticals (PCSA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PCVX Shares Outstanding History PDCO Shares Outstanding History PDEX Shares Outstanding History PDSB Shares Outstanding History PEN Shares Outstanding History PEPG Shares Outstanding History PETV Shares Outstanding History PETX Shares Outstanding History PFE Shares Outstanding History PGEN Shares Outstanding History More Healthcare companies » |
PCSA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
